Germany· DE-A57-2132ff12ad33dac9
Plerixafor Stada
A plerixafor product containing plerixafor, registered in Germany by Stadapharm Gmbh. The same ATC class is registered in 17 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Plerixafor is registered in 17 of 19 countries.
Countries holding a registration under ATC L03AX16 (plerixafor), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 9 of them publish a price we can compare per daily dose
Plerixafor · ATC L03AX16
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Plerixafor
- Manufacturer
- Stadapharm Gmbh
- Country
- Germany (DE)
- ATC code
- L03AX16
- ATC class
- Plerixafor
- Defined daily dose
- 16.8 mg, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Plerixafor in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMozobilSanofi-Aventis U.S. LLC
- SpainMOZOBIL 20 mg/ml SOLUCION INYECTABLESanofi B.V.
- FranceMOZOBIL 20 mg/ml, solution pour injectionSANOFI (PAYS-BAS)
- United KingdomMozobil 24mg/1.2ml solution for injection vialsSanofi
- FinlandMozobilOrifarm Oy
- NetherlandsMozobil 20 mg/ml, oplossing voor injectieGenzyme Europe BV
- SwedenMozobil 20 mg/ml Injektionsvätska, lösningSanofi B.V.
- PolandMozobilSanofi B.V.
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Plerixafor Stada, Plerixafor Teva
- Bulgaria · Plerixafor Msn
- Czechia · Pleforbil, Plerixafor Msn
- Denmark · Plerixafor Seacross, Plerixafor Teva
- Estonia · Plerixafor Auxilia
- Spain · Plerixafor Eugia, Plerixafor Glenmark
- Finland · Plerixafor Seacross, Plerixafor Viatris
- France · Plerixafor Arrow, Plérixafor Eg
- United Kingdom (Northern Ireland) · Plerixafor Amarox Limited, Plerixafor Eugia (Uk)
- Croatia · Pleriksafor Msn, Pleriksafor Onkogen
- Hungary · Plerixafor Msn, Plerixafor Onkogen
- Ireland · Plerixafor Msn Labs Europe, Plerixafor Seacross
- Iceland · Mozobil, Plerixafor Accord
- Italy · Plerixafor Aurobindo, Plerixafor Eg
- Liechtenstein · Mozobil, Plerixafor Accord
- Lithuania · Plerixafor Auxilia
- Netherlands · Plerixafor Amarox, Plerixafor Sandoz
- Norway · Mozobil, Plerixafor Accord
- Poland · Plerixafor Biofar, Plerixafor Msn
- Portugal · Plerixafor Eugia, Plerixafor Mylan
- Romania · Plerixafor Msn Labs Europe
- Sweden · Plerixafor Seacross, Plerixafor Teva
- Slovenia · Pleriksafor Onkogen, Pleriksafor Teva
- Slovakia · Plerixafor Msn, Plerixafor Onkogen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c622b9f6-7200-4880-8d7a-89de2f6cf908 GET /v1/drugs/c622b9f6-7200-4880-8d7a-89de2f6cf908?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Subcutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Plerixafor",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about plerixafor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.